Article & Research Name
(PROTECT) of Hydroxychloroquine, Oseltamivir, and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial.
Extensively Drug-Resistant (XDR) Typhoid: Evolution, Prevention, and Its Management.
Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment.
Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19.
Perindopril, Indapamide and Amlodipine combination leads to significant reduction in SBP and DBP.